Biotest AG (XTER:BIO3) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 21, 2025)

View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Biotest AG's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Biotest AG's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Biotest AG's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotest AG's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest AG's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Biotest AG's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Biotest AG (XTER:BIO3) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Biotest AG Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Biotest AG's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

BTTAY:USA BIESF:USA 0N70:UK BIO3:Austria

Address

Landsteinerstrasse 5, PO Box 10 20 40, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.

Executives

Dr. Katrin Bernöster	Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke	Senior Vice President plasma alliances and proteine supply
Stephan Fleck	Vice President Corporate Controlling
Dr. Jörg Schüttrumpf	VP Corp. Research &Development
Michael Moritz	VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines